Allspring Global Investments
IMCR icon

Allspring Global Investments’s Immunocore IMCR Stock Holding History

Allspring Global Investments’s Portfolio IMCR Stock Details IMCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-87,614
Closed -$5.69M – 2454
2024
Q1 		$5.69M Buy
87,614
+1,830
+2% +$126K 0.01% 923
2023
Q4 		$5.86M Sell
85,784
-22,867
-21% -$1.19M 0.01% 904
2023
Q3 		$5.64M Buy
108,651
+1,513
+1% +$89.5K 0.01% 923
2023
Q2 		$6.42M Buy
107,138
+7,939
+8% +$453K 0.01% 922
2023
Q1 		$4.9M Buy
99,199
+4,291
+5% +$241K 0.01% 1005
2022
Q4 		$5.42M Sell
94,908
-752
-0.8% -$42.3K 0.01% 954
2022
Q3 		$4.49M Buy
+95,660
New +$4.56M 0.01% 996

Other funds holding IMCR

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
GA
General Atlantic New York $2.15B AUM 35.02% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Allspring Global Investments's IMCR Position: Q2 2024 in Review

Allspring Global Investments sold out of Immunocore (IMCR) in Q2 2024, closing a stake of 87,614 shares — an estimated $5.69M sold.

Allspring Global Investments first reported a position in IMCR in Q3 2022 and held it in 7 quarters. The position peaked at $6.42M in Q2 2023. 138 funds tracked by Wall St. Rank hold IMCR as of Q2 2024.

  • Allspring Global Investments reported no remaining Immunocore position as of Q2 2024 after selling out during the quarter.
  • Allspring Global Investments sold 87,614 Immunocore shares in Q2 2024, an estimated $5.69M.
  • Allspring Global Investments first reported a position in Immunocore in Q3 2022 and held it in 7 quarters.
  • Allspring Global Investments's Immunocore position peaked at $6.42M in Q2 2023.
  • 138 funds tracked by Wall St. Rank held Immunocore as of Q2 2024.

Based on Allspring Global Investments's 13F filing for Q2 2024, filed 26 Jul 2024.